PROCEPT BioRobotics (PRCT) Capital Expenditures (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Capital Expenditures for 7 consecutive years, with $3.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures rose 5.39% year-over-year to $3.0 million in Q2 2026; TTM through Jun 2026 was $10.6 million, a 74.73% increase from a year earlier, with the FY2025 full-year figure at $9.4 million, up 112.2% from the prior year.
• Capital Expenditures was $3.0 million for Q2 2026 at PROCEPT BioRobotics, up from $2.9 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $8.7 million in Q4 2023 and troughed at $215000.0 in Q2 2022.
• A 5-year average of $2.7 million and a median of $1.9 million in 2024 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures soared 3491.18% in 2022 and slumped 95.74% in 2024, its largest moves.
• Over 5 years, Capital Expenditures stood at $1.8 million in 2022, then soared by 396.02% to $8.7 million in 2023, then tumbled by 86.53% to $1.2 million in 2024, then surged by 57.58% to $1.8 million in 2025, then jumped by 59.62% to $3.0 million in 2026.
• The last three Capital Expenditures figures came in at $3.0 million (Q2 2026), $2.9 million (Q1 2026), and $1.8 million (Q4 2025), per Business Quant data.